Abstract
We report a patient with chronic hepatitis B infection who developed lymphoma and was treated with concomitant cytotoxic and antiviral therapy. In contrast to the expected life threatening fulminant hepatitis that is often reported in this clinical setting, in our patient normalization of liver function tests with temporary loss of viral replication markers were seen. The implications of this rare clinical and serological course are discussed.
Original language | English |
---|---|
Pages (from-to) | 199-202 |
Number of pages | 4 |
Journal | Leukemia and Lymphoma |
Volume | 36 |
Issue number | 1-2 |
DOIs | |
State | Published - 1999 |
Keywords
- Hepatitis B
- Interferon
- Lymphoma